Log in with your email address username.


[Editorial] Polypills: an essential medicine for cardiovascular disease

Adoption of the notion of a polypill, or fixed-dose combination treatment, to prevent cardiovascular disease has been slow. In today’s Lancet, and ahead of the American College of Cardiology meeting in Washington, DC, USA (March 17–19), we publish a Series of articles that discusses evidence for the use of polypills in the prevention of cardiovascular disease, barriers to acceptance, and ongoing challenges to their widespread use.